Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-17-031642

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nashat Amir Director 2017-05-09 Grant or award · Stock Option (right to buy) +20,000 20,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…